Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Benchling Releases AlphaFold beta Integration

    May 19, 2022, 09:00 AM by User Not Found
    Bio-IT World | Benchling launched its AlphaFold beta feature today, designed to overcome challenges of implementation, computing power, and resourcing to make for ease of experimentation and integration with AlphaFold on the Benchling platform.
    Full story
  • Patient Advocacy Groups Band Together To Further Rare Disease Research

    May 19, 2022, 01:00 AM by User Not Found
    Bio-IT World | The fast-growing Consortium for Outcome Measures and Biomarkers for Neurodevelopmental Disorders (COMBINEDBrain) represents patient advocacy organizations for individuals with rare, neurodevelopmental diseases who are disadvantaged by the small number of affected individuals and scientific brainpower to lead the way.
    Full story
  • Four Well-Established Strategies Used in Hit Identification

    May 18, 2022, 09:21 AM by
    A successful hit identification campaign relies on the use of a high-quality, diverse library of potential compounds to be screened, but also on capitalizing on other complementary techniques, such as structure-based virtual screening (SBVS) and fragment-based screening.
    Full story
  • How to Synthesize Wax Esters? Three Synthetic Routes

    May 18, 2022, 09:21 AM by
    Wax esters are esters formed by long-chain fatty acids and fatty alcohols. Owing to their biodegradability and good lubricity, wax esters can be used as base materials for advanced lubricants and advanced emollient oils for aviation, machinery, and chemical industries as well as for daily cosmetics and other fields. Wax esters can be divided into saturated and unsaturated types.
    Full story
  • CD Formulation: How to Select Pharmaceutical Excipients

    May 18, 2022, 09:21 AM by
    Pharmaceutical excipients refer to the substances used in the production and formulation of medicines. They perform multiple functions in pharmaceutical preparations and are likely to affect the quality, safety and effectiveness of drugs.
    Full story
  • Alfa Chemistry Optimizes Its Microalgae Powder and Related Natural Extract Production Service

    May 18, 2022, 09:21 AM by
    Deeply impressed by the huge potential of microalgae, Alfa Chemistry recently announced to optimize its production systems for microalgae powder and other related natural extracts. This service was first launched a few years ago and ever since then, it has gained over 75 patents in the fields of breeding, cultivation, processing and extract. With a team of biologists, engineers and technicians who are highly experienced with microalgae, the company decides to upgrade its production services by introducing more systematic procedures and more advanced equipment.
    Full story
  • Alfa Chemistry Newly Releases the Offering of Forensic and Veterinary Standards

    May 18, 2022, 09:21 AM by
    Through years of dedicated efforts, Alfa Chemistry has become one of the most popular suppliers of analytical reagents among customers across the globe. Chromatography standards are one of the best-selling categories among all products the company provides, and endeavors have never ceased to enrich such an offering. As a result, this month Alfa Chemistry announces that it has started to offer forensic and veterinary standards, another type of chromatography standards that could be used for forensic and veterinary research.
    Full story
  • Dozens Of New Genetic Risk Factors For Alzheimer’s Disease Identified

    May 18, 2022, 01:00 AM by User Not Found
    Bio-IT World | A meta-analysis of new and previous genome-wide association studies (GWAS) has identified 75 genetic risk factors for Alzheimer’s disease (AD), 42 of which weren’t previously implicated. The investigation confirms the importance of two pathological brain phenomena that are currently pursued therapeutic targets and strengthens the case for having microglial cells join the hit list, according to Jean-Charles Lambert, research director at Inserm (National Institute of Health and Medical Research) based in Lille, France.
    Full story
  • BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421, for Dry Eye Syndrome

    May 17, 2022, 15:46 PM by
    BRIM Biotechnology, Inc. (“BRIM”), a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. (“ORA”), the world’s leading ophthalmic research organization for the late-stage clinical development of lead drug candidate, BRM421, for dry eye syndrome (DES). BRIM intends to initiate Phase 3 clinical studies with Ora’s support later this year.
    Full story
  • Dotmatics supports Umicore Corporate R&D in processing of experimental data

    May 17, 2022, 15:46 PM by
    Full story
  • N4 Pharma highlights potential of Nuvec® as gene therapy delivery platform

    May 17, 2022, 15:46 PM by
    Full story
  • Gainwell Appoints Karen Shields as Chief Client Engagement Officer

    May 17, 2022, 15:46 PM by
    Full story
  • VIDA Introduces New AI-Enabled Biomarker Services

    May 17, 2022, 15:46 PM by
    New VIDA analysis packages & novel biomarkers empower trial sponsors to unlock breakthrough insights
    Full story
  • BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca

    May 17, 2022, 15:46 PM by
    Full story
  • BioIVT to Provide Rare Biosamples for the FNIH Biomarkers Consortium Neurodegenerative Disease Project

    May 17, 2022, 15:46 PM by
    BioIVT is sourcing matched sets of cerebrospinal fluid, serum, and plasma from donors afflicted with ALS to further research of neurofilament in the blood as a biomarker for early stages of neurodegeneration.
    Full story
  • Source the Best PseudoUridines at Industry-Renowned Exhibitions

    May 17, 2022, 15:46 PM by
    BOC Sciences has prepared a long list of first-rate pseudoUridines to be presented at two industry-renowned exhibitions—CPhI North America and TIDES USA 2022. With only a few days away, BOC Sciences sincerely invites all researchers concerned to pay a visit to its booths and have a constructive conversation with its knowledgeable experts.
    Full story
  • Scale-Up Facilities and Leading Expertise Drive Commercial Fermentation Progress

    May 17, 2022, 15:46 PM by
    BOC Sciences provides high-quality antibiotics, bioactive by-products, enzyme inhibitors, mycotoxins, and other fermented products as well as comprehensive CDMO services.
    Full story
  • ArisGlobal Acquires Boehringer Ingelheim’s Signal Analytics Technology

    May 17, 2022, 15:46 PM by
    ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment As a part of the LifeSphere® platform, this solution will be named LifeSphere Clarity and will unlock crucial data patterns leveraging machine learning Rapid, robust benefit-risk assessment is key for all organizations collecting and processing large safety data sets Intelligent tool will drive industry-wide advancement of pharmacovigilance and patient safety capabilities
    Full story
  • Biofourmis Selected by American College of Cardiology as Exclusive Virtual Care Platform to Drive TRANSFORM3 Study Focused on Closing Practice Gaps for Heart Conditions

    May 17, 2022, 15:46 PM by
    The American College of Cardiology (ACC) is leveraging Biofourmis’ AI-based predictive analytics platform and virtual health navigators for ACC’s TRANSFORM(3) study. The study—which focuses on underserved populations with a history of healthcare disparities—will evaluate different intervention strategies for improving adherence to guideline-directed medication therapy (GDMT) for managing specific chronic cardiovascular conditions.
    Full story
  • SeekGene Increases Efficiency by 500% by Leveraging MemVerge Memory Machine in the Cloud

    May 17, 2022, 15:46 PM by
    SeekGene, a biotechnology research firm focusing on single-cell technology, has significantly reduced processing time and cost for data intensive single-cell analysis tasks using MemVerge Memory Machine running on AliCloud i4p compute instances. As a result, SeekGene is able to cut analytical time and costs significantly while optimizing their single-cell sequencing capabilities for researchers worldwide to promote faster development of precision medicine.
    Full story
  • «
  • 141 (current)
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy